Summary
No overall score for this company yet.
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- Revenue fell by 14% a year over the last 3 years.
- You pay -0.0 CAD for 1 CAD of yearly profit, a lot for its sector.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Today you pay -0.0 CAD for 1 CAD of yearly profit.
Valuation in detailIs it growing?
Revenue fell by 6.1% a year over 5 years. Over the last 3 years it fell by 14% a year. Earnings per share fell by 49% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
No balance sheet is available.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
This revenue breakdown is on the way.
By region
This revenue breakdown is on the way.